Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy

Objective: BRCA1 and BRCA2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a different way of thinking about their life plan. We aimed to investigate the distribution of age at diagnosis of ovarian can...

Full description

Bibliographic Details
Main Authors: Arai, M. (Author), Den, H. (Author), Enomoto, T. (Author), Ikeuchi, T. (Author), Nakamura, S. (Author), Nomura, H. (Author), Sekine, M. (Author), the Registration Committee of the Japanese Organization of Hereditary Breast,Ovarian Cancer (Author)
Format: Article
Language:English
Published: Korean Society of Gynecologic Oncology and Colposcopy 2022
Subjects:
Age at Diagnosis
BRCA1
BRCA2
Common Mutation
Ovarian Neoplasms
Risk-Reducing Salpingo-Oophorectomy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items